Cargando…
214. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Negative Panel
BACKGROUND: The ePlex BCID Gram-Negative (GN) panel utilizes electrowetting technology to detect the most common causes of GN bacteremia (21 targets) and 6 antimicrobial resistance genes from positive blood culture bottles. Rapid detection of extended spectrum β-lactamases (ESBL; CTX-M), carbapenema...
Autores principales: | Meeder, Jeremy, Moates, Derek, Pierce, Hannah, Hutchinson, Jamie, Cumagun, Pia, White, Cameron, Lee, Rachael A, McCarty, Todd P, Leal, Sixto M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645031/ http://dx.doi.org/10.1093/ofid/ofab466.416 |
Ejemplares similares
-
200. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Positive Panel
por: Meeder, Jeremy, et al.
Publicado: (2021) -
1022. Evaluating the Impact of GenMark Dx ePlex® Blood Culture Identification (BCID) on Gram-negative Bloodstream Infections
por: Cumagun, Pia, et al.
Publicado: (2021) -
Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: McCarty, T. P., et al.
Publicado: (2023) -
359. The Clinical Utility of the GenMark Dx ePlex® Fungal Blood Culture Identification Panel
por: Carmona, Stefania, et al.
Publicado: (2022) -
The impact of GenMark Dx ePlex blood-culture identification on the treatment and outcomes of gram-positive bacteremia
por: Kiszla, B. Matthew, et al.
Publicado: (2022)